Dr. Abdulmaged M Traish who is the study leader has been encouraging the open study of patients and Doctors to discuss their grievances or their opinions openly for better understanding. He is also reported to stating that patients who are supposed to opt for this 5-a reductase inhibitor therapy should be cautious and have a prior discussion with their doctors regarding their medical condition.